Abstract. Recent advances in stem cell biology have provided new insights that may lead to the development of regeneration therapy in the central nervous system to replenish lost neurons and to reconstitute neural circuits. The strategies for regeneration can be classified into two approaches: i) activation of endogenous neural stem cells and ii) transplantation of donor cells to replace lost cells. In the adult mammalian retina, Müller glia generate new retinal neurons in response to injury. The proliferation and differentiation of Müller glia-derived progenitors can be controlled by both intrinsic and extrinsic factors. Members of the Wnt / β-catenin signaling pathway, such as Wnt receptors and glycogen synthase kinase-3β, may be promising drug targets for neural regeneration. On the other hand, transplantation of photoreceptors or retinal pigment epithelia derived from human embryonic stem cells or induced pluripotent stem cells is also promising. Directed differentiation of pluripotent cells into retinal cells and purification to obtain retinal cells at a specific ontogenetic stage are required for donor cell preparation. Modulation of the host retinal environment to reduce the glial barrier is also critical for transplantation. To restore visual function, we need to understand the mechanisms underlying the integration of newly generated neurons or transplanted cells into the existing neural networks.
Introduction
For many decades, it was believed that neurons in the adult mammalian central nervous system (CNS) could not regenerate after injury, as postulated by Ramón y Cajal in 1913. However, recent evidence has overturned this long-held dogma. Neurogenesis does in fact take place in the adult mammalian CNS, with neural stem cells residing in at least two regions of the brain: the subventricular zone (SVZ) of the lateral ventricle and the subgranular zone (SGZ) of the hippocampal dentate gyrus (1) . Although newly generated neurons may be involved in processes such as learning, memory, and depression, their contribution to and significance for CNS pathophysiology remain poorly understood.
This finding opens up the possibility that the intrinsic ability of CNS cells to self-renew can be harnessed to develop treatments for injuries to the CNS or for diseases in which neurons are lost. Since the eye forms during embryonic development as an outpocketing of the neural tube, progress towards regenerating neurons in the CNS has important implications for retinal regeneration (2) . The retina consists of three cell layers. The outer nuclear layer contains the cell bodies of rod and cone photoreceptors, while the inner nuclear layer (INL) contains the cell bodies of bipolar cells, horizontal cells, amacrine cells, and Müller glia. The ganglion cell layer contains the cell bodies of ganglion cells and displaced amacrine cells. Photoreceptor cells receive and transmit light signals to second order bipolar cells, which relay the information to retinal ganglion cells. Retinal ganglion cells then send signals to lateral geniculate nuclei (LGN) neurons, which provide input to multiple areas of the visual cortex. Since damage to the retina, particularly the photoreceptors, causes irreversible visual impairment, the possibility that lost cells might be replenished and the neural circuitry reconstituted by neural regeneration has received much attention.
The strategies for regeneration can be classified into two approaches: i) activation of endogenous neural stem cells and ii) transplantation of donor cells to replace lost cells. As we learn more about the properties of endogenous neural stem cells, it may be possible to develop treatments in which stem cells in the retina are steered to differentiate into photoreceptors or other differentiated retinal cell types. On the other hand, transplantation of donor cells may be a fruitful approach. If embryonic stem (ES) cells can be differentiated into retinal neurons and transplanted into damaged or diseased retinas, it may be possible to recover some visual function. Moreover, transgenic expression of Oct3 / 4, Sox2, Klf4, and c-Myc in mouse (3) or human (4, 5) somatic cells has been shown to successfully reprogram cells so that they regain their pluripotential state. These induced pluripotent stem (iPS) cells may also be useful for transplantation therapies, particularly because they offer the potential of avoiding immune rejection of transplanted cells without ethical concerns. Here, we review recent findings regarding retinal repair in adult mammals.
Müller glia-derived regeneration in the adult retina
Neurogenic potential of Müller glia
Müller glia form processes that surround neuronal cell bodies in the nuclear layers and contact synapses in the plexiform layers. Their distal processes form the external limiting membrane of the retina, and their endfeet form the inner limiting membrane. Müller glia play important roles in regulating extracellular K + and pH and in the synthesis of the neurotransmitter glutamate.
The possibility that Müller glia might be an endogenous regenerative source was first raised by experiments in goldfish in which laser damage elicited the proliferation of Müller glia and the concomitant replacement of damaged cone photoreceptors (6) . Müller glia in the avian retina have also been reported to possess the regenerative capacity (7) . Moreover, several lines of evidence support a close relationship between Müller glia and retinal progenitors (8 (11 -13) . After proliferation in response to retinal damage, the BrdU-labeled cells migrate into the retinal neuronspecific layer and differentiate into cells positive for retinal neuron-specific markers such as rhodopsin (rod photoreceptors) and PKCα (rod bipolar cells). The Müller glia-derived progenitors appear to differentiate into the type of cell that was damaged, evidenced by the fact that Müller glia generate mainly photoreceptors in the photoreceptor-damaged retina. Moreover, experiments in which several types of neurotoxic injury were administered in the post-hatch chick retina also suggest that the type of neurons injured in the retina allows or promotes the regeneration of that neuronal type (14) . Taken together, these results indicate that Müller glia proliferate and de-differentiate into retinal progenitors in response to retinal damage and then migrate and differentiate into retinal neurons.
The neural stem cell properties of Müller glia have been also verified in vitro (15) . Dissociated Müller glia derived from injured retinas form neurospheres in vitro, as do neural stem / progenitor cells (16, 17) . These neurospheres can differentiate into neurons and glia, demonstrating the multipotency of Müller glia. In addition, Müller glia-derived progenitors can be identified and purified as a distinct population by FACS analysis using Hoechst labeling, another characteristic of progenitor cells (15) . After transplantation into the retina, these Müller glia-derived neurosphere cells can differentiate into retinal neurons (15) .
Control of Müller glia-derived progenitors
In retinal regeneration, the differentiation of Müller glia-derived progenitors can be regulated by both intrinsic and extrinsic factors, similar to what has been observed with retinal progenitors during eye development (11) . In the adult rat retina, retroviral gene transfer of Crx and NeuroD into Müller glia-derived progenitors induces their differentiation into rod photoreceptors (9) . Misexpression of NeuroD and Pax6 induces the differentiation of the progenitors into amacrine cells, and Math3 and Pax6 induce amacrine and horizontal cells after retinal injury. In addition, exogenous application of retinoic acid (10) and Sonic hedgehog (18) induce photoreceptor differentiation. Moreover, NeuroD expression is regulated by histone deacetylases, and the histone deacetylase inhibitor valproic acid induces NeuroD expression in neural stem cells. The application of valproic acid to the damaged retina promotes the differentiation of Müller glia-derived progenitors into photoreceptors (10) .
In addition to cell fate determination, the proliferation of Müller glia-derived progenitors can be regulated by extrinsic factors. Wnt signaling, Notch signaling, and Sonic hedgehog signaling have all been shown to control proliferation (10, 15, 18) . We have found that the Wnt signaling pathway is involved in retinal regeneration and that exogenous application of Wnt3a or Wnt2b increases the number of BrdU-labeled, proliferative cells in the injured retina, thereby increasing the number of newly generated photoreceptors (10) . Interestingly, low molecular weight inhibitors of glycogen synthase kinase-3β (GSK-3β) mimic these effects and similarly promote the proliferation of Müller glia-derived progenitors (10) . However, it should be noted that the degree of degeneration affects the effectiveness of this approach because retinas already exhibiting advanced retinal degeneration do not regenerate with this treatment.
In the canonical pathway, binding of Wnt ligand to its receptor Frizzled and co-receptor LRP5 / 6 inhibits the activity of the destruction complex that degrades β-catenin via an ubiquitin-proteasome, leading to the accumulation of β-catenin in the cytoplasm (Fig. 1) . The accumulated β-catenin translocates into the nucleus, where it binds to lymphoid enhancer-binding factor / T-cell-specific transcription factor (LEF / TCF) transcription factors and then activates the transcription of target genes such as cyclin D1. Accumulating evidence points to a role for Wnt / β-catenin signaling in regulating various types of stem cells. In the adult hippocampus, Wnt3 derived from astrocytes promotes neuronal differentiation and enhances adult neurogenesis (19) . Activation of β-catenin signaling by GSK-3β inhibitors increases the proliferation of neural stem cells in the SVZ, thereby promoting neurogenesis in the olfactory bulb (20) . Thus, Wnt signaling may be a part of the natural regeneration mechanisms in the adult CNS.
Cell transplantation
ES cells are pluripotent cells derived from the inner cell mass of blastocyst stage embryos. They can maintain an undifferentiated state indefinitely in vitro and differentiate into derivatives of all three germ layers: the ectoderm, endoderm, and mesoderm. These characteristics make ES cells an attractive potential donor source for cell replacement therapies in tissues damaged by disease or injury. The treatment strategy of cell replacement is not new; dopaminergic neurons and retinal cells derived from fetal tissues have been transplanted into the adult striatum and eye, but because fetal tissues are limited in supply and ethically problematic, many efforts have been made to find alternative cell sources. Recent progress in the in vitro culture and differentiation of human ES cells has raised the possibility of using ES cell derivatives for cell transplantation therapy (2) .
For photoreceptor transplantation, the stage and differentiation state of donor cells are important (21) (Fig. 2) . P3-6 post-mitotic rod precursors are capable of integration when transplanted into the normal adult or degenerating retina, whereas proliferating progenitors or stem cells are not. The transplanted P3-6 photoreceptors are able to form functional synaptic connections with host bipolar cells and improve visual function. These results indicate that using cells already committed to photoreceptors rather than less committed retinal progenitors is crucial for successful integration. Thus, identification of appropriate surface antigens marking P3-6 photoreceptors should be crucial for future transplantation studies.
While somatic progenitors derived from the cilliary body (22) or iris (23) are limited in both differentiation potential and proliferation capacity, human ES cells can generate a large number of retinal cells. For this reason, retinal cells differentiated from ES cells are more suitable as donor cells for transplantation. In order to obtain transplantable retinal cells from ES cells, the developmental processes that regulate retinal differentiation must be at least in part recapitulated in vitro (2, 24, 25) . We have been able to induce differentiation of ES cells in a stepwise fashion; ES cells are first differentiated into retinal progenitors (Rax+, Mitf+, Pax6+) and then to retinal pigment epithelia (RPE) and photoreceptors. We have also succeeded in generating photoreceptors and retinal pigment epithelia from human ES cells under defined conditions (25) . It is important to note that because xenogenic factors may cause rejection by the immune system following transplantation (26) , the generation of differentiated cells from human ES cells without contamination from other animal-derived substances is essential for the clinical application of transplantation strategies.
The host environment is also critical for photoreceptor transplantation. The glial barrier in the host retina prevents integration of donor photoreceptors. However, robust integration of transplanted retinal cells into the retina of host mice deficient in both vimentin and glial fibrillary acidic protein has been reported (27) . Moreover, chondroitinases and matrix metalloproteases-2 that degrade the extracellular matrix in the diseased retina aid in the integration of transplanted photoreceptors (28, 29) . Disruption of the outer limiting membrane also increases photoreceptor integration following transplantation (30) .
In addition to photoreceptors, the regeneration of RPE is important. RPE cells are essential for maintenance of retinal function, particularly for outer segment shedding, supplying nutrients to the retina, and maintaining the blood-retinal barrier. For example, in age-related macular degeneration, RPE cells are damaged, resulting in secondary loss of photoreceptors. We have demonstrated that transplantation of RPE cells derived from monkey ES cells can restore visual function in a retinal degeneration model, RCS rats (31) . Human ES cellderived RPE has also been shown to be effective for functional recovery in RCS rats (32) .
In clinical trials, adverse effects after surgery, including tumors or vigorous immune reactions, must be avoided. To avoid tumor formation, we must establish methods to purify transplanted cells to exclude undifferentiated cells. In terms of the immune reaction, administration of immunosuppressant drugs is generally re- Fig. 1 . Canonical Wnt signaling pathway. A: In the absence of Wnts, β-catenin forms a complex with Axin, APC, and GSK-3β; and it is degraded by the ubiquitin-proteasome system. B: When Wnts bind their receptors, such as Frizzled and LRP, GSK-3β is inactivated via Dishevelled. Cytoplasmic β-catenin is stabilized and the accumulated β-catenin is translocated into the nucleus, resulting in the activation of the transcription factor, LEF /TCF. LRP, low-density lipoprotein receptor-related protein; APC, adenomatous polyposis coli; GSK-3β, glycogen synthase kinase-3β; LEF /TCF, lymphoid enhancer-binding factor / Tcell factor. quired; however, iPS cells may circumvent this problem. Expressions of Oct3 / 4, Sox2, and Klf4 are able to reprogram patients' cells so that they may produce their own iPS cells (4, 5) . Although it is unclear whether or not iPS cells are completely equivalent to ES cells, retinal cells differentiated from patient-specific iPS cells could enable non-immunogenic autograft.
Concluding remarks
Since Müller glia are a potential source of neural regeneration in the adult mammalian retina, developing drugs that target these cells is a promising approach that may lead to new retinal regeneration therapies. In particular, signaling component molecules of the Wnt / β-catenin pathway are potential drug targets. Lowmolecular compounds that stimulate the Wnt / β-catenin signaling, such as Wnt receptor agonists and GSK-3β inhibitors, may have therapeutic potential (Fig. 1) .
It should be noted that mammalian aging is associated with reduced regenerative capacity in tissues containing stem cells. Several lines of evidence indicate that this decrease in regeneration potential is partly due to the senescence of progenitors with age (33) . It is also important to note that the progression of disease may restrict the potential degree of recovery. However, the generation of cloned animals (34) and iPS cells (3 -5) indicate that cells can in fact be reprogrammed, if epigenetic regulation of the genome can be altered. Therefore, better control of the epigenetic state of progenitor cells may allow us to prevent their senescence and reduction in potential and to restore differentiation and proliferation potential.
Finally, despite the neurogenic properties of Müller glia, there is no direct evidence that Müller glia-derived neurons contribute to the functional regeneration of the retina in vivo. In retinal neural circuits, cone and rod photoreceptors have different pathways in visual transduction (35) . Cone photoreceptors connect with ON or OFF cone bipolar cells, which make synaptic contacts with retinal ganglion cells (Fig. 3A) . In contrast, rod photoreceptors connect to ON rod bipolar cells, which subsequently send the signal to AII amacrine cells. The AII amacrine cells send the information to ON or OFF cone bipolar cells, which make synapses to ON or OFF ganglion cells, respectively (Fig. 3B) . Horizontal cells provide negative feedback to photoreceptors. For retinal regeneration therapy to become a reality, we need to elucidate the mechanisms underlying the integration of newly generated neurons or transplanted cells into the existing neural networks and functional recovery in animal models closely resembling human diseases. 
